Literature DB >> 1961259

Hydrophobic properties of novel dihydronaphthyridine calcium antagonists and biological activity in porcine isolated cardiac and vascular smooth muscle.

G Werner1, W Klaus, G Kojda, U Fricke.   

Abstract

Dihydronaphthyridine calcium antagonists are structurally related to the well known dihydropyridines and act in a similar manner. In order to establish the vascular selectivity of these compounds contractile force was evaluated in porcine isolated ventricular trabeculae and right coronary arteries. The dihydropyridine derivatives nisoldipine and nitrendipine as well as the structurally different compounds gallopamil and flunarizine were included for comparison purpose. All compounds studied exhibited dose-dependent negative inotropic and vasodilator activities. The negative inotropic potency of all dihydronaphthyridines, especially of the highly lipophilic bulky ester-variated derivatives (Goe 5584-A, Goe 5806-A) was comparable to that of flunarizine but was considerably less pronounced than that of nisoldipine, nitrendipine or gallopamil. By contrast, half-maximal vasodilator responses of the dihydronaphthyridines studied in coronary arteries being in the nanomolar concentration range were comparable to the dihydropyridines nisoldipine and nitrendipine, whereas the activity of gallopamil and flunarizine was less marked. On the other side the dihydronaphthyridines, especially the more hydrophilic 3-ethylester-4-(2-cyanophenyl) derivative Goe 5606, exerted an obvious biphasic concentration-response behaviour in coronary arteries leading to a high affinity relaxant process in subnanomolar concentrations, whereas the low affinity response could be observed at rather high concentrations (mostly greater than 1 microM). Mainly due to their relative uneffectiveness in cardiac muscle, vascular selectivity of the dihydronaphthyridines was considerably higher than that of the structurally related dihydropyridines nisoldipine resp. nitrendipine increasing in the following order: nitrendipine less than nisoldipine less than Goe 5606 less than Goe 5438 less than Goe 5584-A less than Goe 5806-A. By contrast, gallopamil exerted a slight cardiac preference, whereas the vascular selectivity of flunarizine was also pronounced.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1961259     DOI: 10.1007/bf00183009

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

1.  A novel type of cardiac calcium channel in ventricular cells.

Authors:  B Nilius; P Hess; J B Lansman; R W Tsien
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

2.  Pharmacologic relevance of dihydropyridine binding sites in membranes from rat aorta: kinetic and equilibrium studies.

Authors:  M Wibo; L DeRoth; T Godfraind
Journal:  Circ Res       Date:  1988-01       Impact factor: 17.367

3.  Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers.

Authors:  D W Chester; L G Herbette; R P Mason; A F Joslyn; D J Triggle; D E Koppel
Journal:  Biophys J       Date:  1987-12       Impact factor: 4.033

4.  Electromechanical and pharmacomechanical coupling in vascular smooth muscle.

Authors:  A V Somlyo; A P Somlyo
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

5.  Mathematical analysis of concentration-response relationships. Method for the evaluation of the ED50 and the number of binding sites per receptor molecule using the logit transformation.

Authors:  D Hafner; E Heinen; E Noack
Journal:  Arzneimittelforschung       Date:  1977

Review 6.  Cellular action of calcium channel blocking drugs.

Authors:  A Schwartz; D J Triggle
Journal:  Annu Rev Med       Date:  1984       Impact factor: 13.739

7.  Stereoselective inhibition of calmodulin-dependent cAMP phosphodiesterase from bovine heart by (+)- and (-)-nimodipine.

Authors:  C Schächtele; B Wagner; D Marmé
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

8.  Theoretical bases for vascular selectivity of Ca2+ antagonists.

Authors:  C Cauvin; S Lukeman; J Cameron; O Hwang; K Meisheri; H Yamamoto; C van Breemen
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

9.  Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries.

Authors:  A Karasawa; K Kubo
Journal:  Jpn J Pharmacol       Date:  1988-05

10.  PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.

Authors:  R P Hof; G Scholtysik; R Loutzenhiser; H J Vuorela; P Neumann
Journal:  J Cardiovasc Pharmacol       Date:  1984 May-Jun       Impact factor: 3.105

View more
  1 in total

1.  The effect of the calcium-antagonist nitrendipine on intracellular calcium concentration in endothelial cells.

Authors:  A Salameh; G Schomecker; K Breitkopf; S Dhein; W Klaus
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.